A major risk of breast cancer screening may have been overestimated for decades

A new analysis reexamined all eight major randomized screening trials, accounting for differences in follow-up time, screening frequency, and screening after the trials ended. Its results were consistent with an overdiagnosis rate below 5%, rather than earlier estimates approaching 30% to 50%, suggesting mammography overdiagnosis may be far lower than some prior studies indicated.

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.